Drugs / APSCTC
last change Oct 2024 re-read 2 minutes ago

APSCTC

Investigated by
Apsen Farmaceutica S.A.

Trials 1 · a red edge is where a trial was stopped

202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT04647435 May 2023 → Oct 2024 Apsen Farmaceutica S.A. Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as APSCTC “Drug: APSCTCNCT04647435
Route Oral Oral tablets every 6h for 3 days” NCT04647435